A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer
Sandani De Vass Gunawardane, Matheen Muhammadh Milhan, Poorni Chanuka Rathnayaka, Prabudhi S. Garusinghe, Kavishka S. Gunaratne, Anusha Kanagasundaram, T.M.D Darshanamala, Duvinika Chalani Senevirathne, Shalini K. Wijerathne, Chamudi Perera, Kanishka Sithira Senathilake, Umapriyathrashini Rajagopalan, Kamani Hemamala Tennekoon, Sameera R. Samarakoon
This study uses network pharmacology and molecular docking to explore Vernolac's anticancer mechanisms, identifying key phytochemicals and pathways involved in apoptosis, immune modulation, and chemoradiosensitization.
PLoS ONE · Jul 1, 2026Peer-reviewedBioinformatics